| Jun 30, 2026 | Stephenson Brian CChief Financial Officer | Purchase at price 22.95 - 24.98 per share. | 13.6K | $326.13K |
| Jun 25, 2026 | Stephenson Brian CChief Financial Officer | Purchase at price 23.61 - 27.77 per share. | 15.6K | $401.27K |
| Jun 22, 2026 | Stephenson Brian CChief Financial Officer | Purchase at price 20.23 - 25.91 per share. | 17.4K | $405.92K |
| Jun 21, 2026 | Parikh Anand Kiran J.D.Chief Executive Officer | Purchase at price 19.76 per share. | 2.8K | $55.45K |
| Jun 21, 2026 | Parikh Anand Kiran J.D.Chief Executive Officer | Conversion of Exercise of derivative security at price 1.16 per share. | 53.5K | $62.02K |
| Jun 14, 2026 | Parikh Anand Kiran J.D.Chief Executive Officer | — | 761.4K | — |
| Jun 14, 2026 | Hahn Stephen MDirector | — | 44.8K | — |
| May 31, 2026 | Peyer JamesBeneficial Owner of more than 10% of a Class of Security | Sale at price 20.00 - 21.14 per share. | 25K | $500.54K |
| May 31, 2026 | Cambrian Biopharma IncBeneficial Owner of more than 10% of a Class of Security | Sale at price 20.00 - 21.14 per share. | 25K | $500.54K |
| Apr 6, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Purchase at price 31.02 - 35.55 per share. | 4.2K | $141.36K |
| Apr 6, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Sale at price 28.94 - 34.80 per share. | 17.1K | $538.11K |
| Mar 31, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Purchase at price 25.32 - 35.46 per share. | 12.2K | $386.31K |
| Mar 31, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Sale at price 27.11 - 34.75 per share. | 2.7K | $86.28K |
| Mar 29, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Purchase at price 25.08 - 29.98 per share. | 30.6K | $818.26K |
| Mar 29, 2026 | Millennium Management, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.85 - 28.69 per share. | 3.3K | $89.39K |
| Dec 8, 2025 | Peyer JamesBeneficial Owner of more than 10% of a Class of Security | Sale at price 7.92 - 8.59 per share. | 6.6K | $54.58K |
| Dec 8, 2025 | Peyer JamesBeneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 6.40 per share. | 395 | $2.53K |
| Dec 8, 2025 | Cambrian Biopharma IncBeneficial Owner of more than 10% of a Class of Security | Sale at price 7.92 - 8.59 per share. | 6.6K | $54.58K |
| Dec 8, 2025 | Cambrian Biopharma IncBeneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 6.40 per share. | 395 | $2.53K |
| Dec 4, 2025 | Peyer JamesBeneficial Owner of more than 10% of a Class of Security | Sale at price 9.06 - 11.40 per share. | 21.3K | $228.06K |
